AptarGroup (NYSE:ATR) Announces Earnings Results, Beats Estimates By $0.01 EPS

AptarGroup (NYSE:ATR) issued its quarterly earnings data on Thursday. The industrial products company reported $1.37 EPS for the quarter, topping the consensus estimate of $1.36 by $0.01, Briefing.com reports. The business had revenue of $910.10 million during the quarter, compared to analyst estimates of $930.15 million. AptarGroup had a net margin of 9.00% and a return on equity of 15.31%. During the same period last year, the business posted $1.23 earnings per share. AptarGroup’s quarterly revenue was up 1.6% compared to the same quarter last year. AptarGroup updated its Q3 2024 guidance to 1.380-1.460 EPS and its Q3 guidance to $1.38-1.46 EPS.

AptarGroup Stock Up 3.7 %

NYSE:ATR traded up $5.17 during trading hours on Friday, reaching $146.66. 562,787 shares of the company traded hands, compared to its average volume of 259,725. AptarGroup has a 1 year low of $118.74 and a 1 year high of $151.73. The stock has a market capitalization of $9.72 billion, a P/E ratio of 31.47, a P/E/G ratio of 3.12 and a beta of 0.57. The business’s 50-day moving average price is $145.05 and its two-hundred day moving average price is $141.10. The company has a current ratio of 1.30, a quick ratio of 0.89 and a debt-to-equity ratio of 0.29.

AptarGroup Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Thursday, July 25th will be given a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a yield of 1.23%. The ex-dividend date of this dividend is Thursday, July 25th. This is a positive change from AptarGroup’s previous quarterly dividend of $0.41. AptarGroup’s dividend payout ratio (DPR) is 38.63%.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on ATR shares. William Blair upgraded AptarGroup from a “market perform” rating to an “outperform” rating in a research note on Monday, April 29th. Wells Fargo & Company raised their price objective on AptarGroup from $163.00 to $168.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Finally, Robert W. Baird upped their target price on shares of AptarGroup from $150.00 to $170.00 and gave the stock an “outperform” rating in a research report on Monday, April 29th.

Insider Activity

In other AptarGroup news, insider Hedi Tlili sold 4,634 shares of the firm’s stock in a transaction dated Wednesday, May 1st. The shares were sold at an average price of $145.09, for a total transaction of $672,347.06. Following the completion of the sale, the insider now directly owns 9,379 shares in the company, valued at approximately $1,360,799.11. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, insider Hedi Tlili sold 4,634 shares of the company’s stock in a transaction that occurred on Wednesday, May 1st. The stock was sold at an average price of $145.09, for a total value of $672,347.06. Following the transaction, the insider now directly owns 9,379 shares of the company’s stock, valued at approximately $1,360,799.11. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Kimberly Chainey sold 825 shares of the stock in a transaction on Thursday, June 6th. The shares were sold at an average price of $146.77, for a total value of $121,085.25. Following the sale, the executive vice president now owns 8,812 shares in the company, valued at $1,293,337.24. The disclosure for this sale can be found here. Insiders sold 8,659 shares of company stock worth $1,269,976 over the last three months. 1.00% of the stock is currently owned by corporate insiders.

AptarGroup Company Profile

AptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments.